tm
Seeing Is Believing
tm
Seeing Is Believing
Spring Bank Pharmaceuticals's activity chart (see below) currently has 3 price targets and 3 ratings on display.
Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 312.67 days.
Most recent stock forecast was given by MAURY RAYCROFT from JEFFERIES on 29-Jan-2020. First documented stock forecast 19-May-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jan-2020
$1.5
$-3.34 (-69.01%)
$28
6 years 8 months 18 days ago
(29-Jan-2020)
1/2 (50%)
$-3.82 (-71.80%)
195
Buy Since 26-Dec-2019
$2
6 years 9 months 21 days ago
(26-Dec-2019)
0/1 (0%)
$-12.44 (-86.15%)
Buy Since 19-May-2017
$20
$15.16 (313.22%)
$20
8 years 2 months 14 days ago
(03-Aug-2018)
2/2 (100%)
$-36.48 (-64.59%)
527
Buy Since 01-Aug-2017
$30
$25.16 (519.83%)
$30
8 years 11 months 11 days ago
(06-Nov-2017)
2/2 (100%)
$-37.08 (-55.28%)
577
What is SBPH (Spring Bank Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on SBPH (Spring Bank Pharmaceuticals)?
Which analyst has the most public recommendations on SBPH (Spring Bank Pharmaceuticals)?
Which analyst is the currently most bullish on SBPH (Spring Bank Pharmaceuticals)?
Which analyst is the currently most reserved on SBPH (Spring Bank Pharmaceuticals)?
